| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/2003 | EP1307193A1 Agonists of follicle stimulating hormone activity |
| 05/07/2003 | EP1307192A1 New use of angiotensin ii antagonists |
| 05/07/2003 | EP1307191A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 05/07/2003 | EP1307190A1 Use of il-8 receptor antagonists in the treatment of virus infections |
| 05/07/2003 | EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 05/07/2003 | EP1307188A1 Cannabinoid drugs |
| 05/07/2003 | EP1307187A2 Use of 13-cis retinoic acid for the treatment of emphysema |
| 05/07/2003 | EP1307186A1 Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids |
| 05/07/2003 | EP1307185A2 Method for the prevention and treatment of retinopathy |
| 05/07/2003 | EP1307184A2 Drugs for incontinence |
| 05/07/2003 | EP1307183A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 05/07/2003 | EP1307182A2 Pharmaceutical composition for transdermal delivery of befloxatone |
| 05/07/2003 | EP1307181A1 Novel compositions of minoxidil |
| 05/07/2003 | EP1307180A1 A method of preparing a pharmaceutical composition |
| 05/07/2003 | EP1307108A2 Oil/fat composition |
| 05/07/2003 | EP1307107A2 Oil/fat composition |
| 05/07/2003 | EP1307104A1 A new antibacterial composition comprising as an active ingredient saponificated vegetable oil |
| 05/07/2003 | EP1233788B1 Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan |
| 05/07/2003 | EP1232165B1 Phosphorus-containing dendrimers as transfection agents |
| 05/07/2003 | EP1216043B1 Retard form containing alpha-lipoic acid (derivatives) |
| 05/07/2003 | EP1204658B1 Benzofurylpiperazine serotonin agonists |
| 05/07/2003 | EP1200106B1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 05/07/2003 | EP1165065B1 Swallowable tablets with high content of n-acetylcysteine |
| 05/07/2003 | EP1147110B1 Pyrazino(aza)indole derivatives |
| 05/07/2003 | EP1140825B1 Melatonin derivatives and medicine containing same |
| 05/07/2003 | EP1124544B1 Dry powder pharmaceutical formulation |
| 05/07/2003 | EP1121105A4 Propofol-based anesthetic and method of making same |
| 05/07/2003 | EP1112251B1 Azetidine derivatives, preparation and medicines containing them |
| 05/07/2003 | EP1109532A4 Oral micro-emulsion composition of silybin |
| 05/07/2003 | EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 05/07/2003 | EP1097698B1 Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain |
| 05/07/2003 | EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules |
| 05/07/2003 | EP1095017B1 24,24-difluorinated analogs of 1-alpha,25-dihydroxy vitamin d3 |
| 05/07/2003 | EP1090004B1 A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom |
| 05/07/2003 | EP1086079B1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids |
| 05/07/2003 | EP1061963B1 Protease inhibitors in absorbent articles |
| 05/07/2003 | EP1058681B1 Novel allylthiopyridazine derivatives and process for preparing the same |
| 05/07/2003 | EP1054863B1 2-aminoquinoline derivatives having d4-agonistic activity |
| 05/07/2003 | EP1054681B1 The use of combinations of active agents consisting of antibiotics and plant extracts containing terpene in veterinary medicine |
| 05/07/2003 | EP1049460B1 Method for the prophylactic treatment of mastitis |
| 05/07/2003 | EP1045822B1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| 05/07/2003 | EP1033987B1 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 05/07/2003 | EP1032414B1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 05/07/2003 | EP1027361B1 6,11-bridged erythromycin derivatives |
| 05/07/2003 | EP1023051B1 Oral morphine multiparticulate formulation |
| 05/07/2003 | EP1019358B1 3,3-diarylpropylamines , their use and preparation |
| 05/07/2003 | EP1019055B1 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 05/07/2003 | EP1007023B1 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine derivatives for lowering the uric level in humans |
| 05/07/2003 | EP1001956B1 2,3-benzodiazepine derivatives |
| 05/07/2003 | EP0998287B1 Use of levobupivacaine |
| 05/07/2003 | EP0987267B1 Carbapenem compounds, use thereof, and intermediate compounds of the same |
| 05/07/2003 | EP0981527B1 Salt of naphthyridine carboxylic acid derivative |
| 05/07/2003 | EP0973511B1 Use of sibutramine analogues to lower lipid levels |
| 05/07/2003 | EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 05/07/2003 | EP0966287B1 Oxacarbazepine film-coated tablets |
| 05/07/2003 | EP0959876B1 Method for separating active substances in solid pharmaceutical preparations |
| 05/07/2003 | EP0954281B1 Moistening preparation |
| 05/07/2003 | EP0912520B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 05/07/2003 | EP0907365B1 Novel formulation |
| 05/07/2003 | EP0900076B1 Transdermal device |
| 05/07/2003 | EP0893997B1 Paroxetine in treatment of depression |
| 05/07/2003 | EP0889880B1 Eprosartan dihydrate and a process for its production and formulation |
| 05/07/2003 | EP0888330B1 Methods of treating or preventing interstitial cystitis |
| 05/07/2003 | EP0885190B1 N-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
| 05/07/2003 | EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS |
| 05/07/2003 | EP0869791B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| 05/07/2003 | EP0858464B1 Thrombin inhibitors |
| 05/07/2003 | EP0854712B1 Use of creatine analogues for the treatment of disorders of glucose metabolism |
| 05/07/2003 | EP0841929B1 Quinolones and their therapeutic use |
| 05/07/2003 | EP0836648B1 Recombinant mva virus, and the use thereof |
| 05/07/2003 | EP0835114B1 Pharmaceutical combined preparation, kit and method for hormonal contraception |
| 05/07/2003 | EP0821687B1 Preparation of clavulanate salts |
| 05/07/2003 | EP0814807B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/07/2003 | EP0812184B1 Nitric oxide synthase inhibitors |
| 05/07/2003 | EP0808174B1 Medicament in particle form |
| 05/07/2003 | EP0806416B1 Huperzine a derivatives, their preparation and their use |
| 05/07/2003 | EP0804247B1 Selenium conjugates for the preparation of free radical pharmaceuticals |
| 05/07/2003 | EP0799219B1 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 05/07/2003 | EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha) |
| 05/07/2003 | EP0774961B1 Use of selegilin in the treatment of epilectic conditions |
| 05/07/2003 | EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 05/07/2003 | EP0752861B1 use of STEROID 5-ALPHA-REDUCTASE INHIBITORS in the manufacture of a medicament for TREATING CARDIOVASCULAR DISEASE |
| 05/07/2003 | EP0751765B1 Sulfonamide derivatives and their use |
| 05/07/2003 | EP0749417B1 Cyano compounds and preparations thereof |
| 05/07/2003 | EP0741570B1 Preventing or reducing photosensitivity and/or phototoxicity reactions to antiinfective medications |
| 05/07/2003 | EP0719272B1 Pyrimidine derivatives for labeled binding partners |
| 05/07/2003 | EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 05/07/2003 | EP0614898B1 Indole derivative, process for producing the same, and medicinal use thereof |
| 05/07/2003 | CN1416431A Nucleoside compounds and uses thereof |
| 05/07/2003 | CN1416430A 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents |
| 05/07/2003 | CN1416428A Compounds having antitumor activity: process for their prepn.and pharmaceutical compsns. contg. them |
| 05/07/2003 | CN1416425A 1,5-bemzothiazepines and their use as hypolipidaemics |
| 05/07/2003 | CN1416424A Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 05/07/2003 | CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 05/07/2003 | CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles |
| 05/07/2003 | CN1416420A 1,2,3,4-tetrahydroisoquinoline derivatives |
| 05/07/2003 | CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia |
| 05/07/2003 | CN1416411A Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome |
| 05/07/2003 | CN1416353A Anti-infective active substance combinations and use thereof for topical treatment of fungus diseases of toe and finger nails |
| 05/07/2003 | CN1416347A Agent for treating hepatitis C |